Evasion of COPD in smokers: at what price?

被引:22
作者
Cosio, Manuel G. [2 ,3 ]
Saetta, Marina [1 ]
机构
[1] Univ Padua, Clin Pneumol, Dept Cardiac Thorac & Vasc Sci, Sect Resp Dis, I-35128 Padua, Italy
[2] McGill Univ, Royal Victoria Hosp, Dept Med, Div Resp, Montreal, PQ H3A 1A1, Canada
[3] McGill Univ, Royal Victoria Hosp, Dept Med, Meakins Christie Labs, Montreal, PQ H3A 1A1, Canada
关键词
Cancer; chronic obstructive pulmonary disease; immune response; monocyte/macrophage; T-LYMPHOCYTE RESPONSE; CIGARETTE-SMOKE; SUPPRESSOR-CELLS; LUNG-CANCER; INFLAMMATION; AIRWAYS; MECHANISMS; EXPRESSION; MALIGNANCY; RESOLUTION;
D O I
10.1183/09031936.00135711
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Investigations toward the understanding of chronic obstructive pulmonary disease (COPD) have been directed, so far, to the study of mechanisms leading to the disease. We believe that understanding why similar to 80% of smokers evade COPD and how this evasion is accomplished might be a fruitful endeavour that could advance knowledge of the development of the disease. Since the inflammatory infiltrate smokers develop seems to be the key element leading to the lung destruction in COPD, the understanding of the possible ways inflammation can be dampened, as well as its consequences, ought to be important. We review here some of the mechanisms by which inflammation is controlled: by the post-translational regulons, by the mechanisms preventing full activation of dendritic cells and by the regulatory T-cells. The potential role of the M2 alveolar macrophage phenotype and the newly described myeloid-derived suppressor cells is mentioned. We also point out that evasion comes at a price, as healthy smokers might be immunosuppressed to some extent and unable to prevent the development of cancer, certainly less so than in severe COPD, where immunity is heightened. Probably, the knowledge of the mechanisms of evasion from COPD could add significantly to the understanding of those leading to the disease.
引用
收藏
页码:1298 / 1303
页数:6
相关论文
共 50 条
  • [41] COPD in exclusive narghile smokers: Some points to verify
    Ben Saad, Helmi
    CHRONIC RESPIRATORY DISEASE, 2017, 14 (04) : 420 - 421
  • [42] Oxidative stress and lung function profiles of male smokers free from COPD compared to those with COPD: a case-control study
    Ben Moussa, Syrine
    Sfaxi, Ines
    Tabka, Zouhair
    Ben Saad, Helmi
    Rouatbi, Sonia
    LIBYAN JOURNAL OF MEDICINE, 2014, 9
  • [43] Proteomic Analysis in Lung Tissue of Smokers and COPD Patients
    Lee, Eun Joo
    In, Kwang Ho
    Kim, Je Hyeong
    Lee, Sang Yeub
    Shin, Chol
    Shim, Jae Jeong
    Kang, Kyung Ho
    Yoo, Se Hwa
    Kim, Chul Hwan
    Kim, Han-Kyeom
    Lee, Sang Hoon
    Uhm, Chang Sub
    CHEST, 2009, 135 (02) : 344 - 352
  • [44] Serum Levels of Autoantibodies Against Extracellular Antigens and Neutrophil Granule Proteins Increase in Patients with COPD Compared to Non-COPD Smokers
    Ma, Aiping
    Wen, Lifang
    Yin, Junping
    Hu, Yi
    Yue, Xiaoyang
    Li, Jiurong
    Dong, Xiaoru
    Gupta, Yask
    Ludwig, Ralf Joachim
    Krauss-Etschmann, Susanne
    Riemekasten, Gabriela
    Petersen, Frank
    Yu, Xinhua
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 189 - 200
  • [45] Predisposing factors for COPD in young active and passive smokers
    Gaki, E.
    Spyropoulos, K.
    Karkoulias, K.
    Fouzas, S.
    Spyropoulou, A. P.
    Spyropoulos, V.
    Spyropoulou, G.
    Lykouras, D.
    Lagiou, O.
    ARCHIVES OF HELLENIC MEDICINE, 2024, 41 (01): : 83 - 90
  • [46] Evaluation of Salivary Biomarkers and Spirometry for Diagnosing COPD in Non-Smokers and Smokers of Polish Origin
    Rudzinska-Radecka, Magdalena
    Bancerowski, Bartlomiej
    Marczynski, Robert
    Mukherjee, Debjita
    Sikora, Tomasz
    Morawska, Karolina
    Mielczarek, Agnieszka
    Mozdzierski, Marcin
    Hajduk, Bogdan
    Kotowicz, Beata
    BIOMEDICINES, 2024, 12 (06)
  • [47] Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD
    Agne Babusyte
    Kristina Stravinskaite
    Jolanta Jeroch
    Jan Lötvall
    Raimundas Sakalauskas
    Brigita Sitkauskiene
    Respiratory Research, 8
  • [48] The Microbiome in Bronchial Biopsies from Smokers and Ex-Smokers with Stable COPD - A Metatranscriptomic Approach
    Ditz, B.
    Boekhoudt, J.
    Couto, N.
    Brandsma, C. A.
    Hiemstra, P. S.
    Tew, G. W.
    Neighbors, M.
    Grimbaldeston, M. A.
    Timens, W.
    Kerstjens, H. A. M.
    Rossen, J. W. A.
    Guryev, V
    van den Berge, M.
    Faiz, A.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 19 (01) : 81 - 87
  • [49] Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers
    de Oliveira Caram, Laura Miranda
    Ferrari, R.
    Nogueira, D. L.
    Oliveira, M. R. M.
    Francisqueti, F. V.
    Tanni, S. E.
    Correa, C. R.
    Godoy, I.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 2015 - 2021
  • [50] What price cure?
    Kunkler, Ian
    LANCET ONCOLOGY, 2012, 13 (01) : E2 - E2